Home » Business » The Indonesian Covid-19 Case Is More Horrified, Foreigners Flee & IHSG Spread

The Indonesian Covid-19 Case Is More Horrified, Foreigners Flee & IHSG Spread

Jakarta, CNBC Indonesia– Pressure on the domestic stock market occurred during the trading weekend Friday (4/12/20). The negative sentiment of cases increases Covid-19 and the lack of raw materials for the manufacture of vaccines has made investors refrain and some are taking profit.

In today’s close of trading, IHSG corrected 0.21% to the level of 5,810.48. The transaction value has reached IDR 13.06 trillion and foreign net sell in all markets is IDR 84.5 billion. 195 shares shot, 265 shares were corrected, and the remaining 162 shares were stagnant.

Stock-shares released by investors foreign among others, saham PT Bank Rakyat Indonesia Tbk (BBRI) was corrected 2.27% to the price of Rp.4,300 / unit because it was sold by foreigners for Rp. 126.9 billion and shares of PT Telekomunikasi Indonesia Tbk (TLKM) which were sold at a net Rp. 125.5 billion, so a drop of 1.52% to the price of Rp. 3,250 / unit.


Soaring The daily positive case of the Corona virus in Indonesia which reached 8,363 on last Thursday, December 4, 2020 could be a negative sentiment for stock trading this weekend.

Spokesperson for the Handling Task Force Covid-19, Prof. Wiku Adisasmito, even said the addition of such cases could not be tolerated.

“We can see that in the last few days we have set new records. Previously we have never reached above 5,000, but unfortunately positive cases are increasing, even per day, reaching more than 8,000 cases. This is a very large number and cannot be tolerated. “said Prof. Wiku, in a press conference on Thursday (3/12/2020).

Furthermore, negative sentiment also came from the giant pharmaceutical company Pfizer, announcing that it would only be able to deliver half of the total vaccine targetCovid-19 this year.

Pfizer says a co-developed vaccine BioNTech This is a shortage of raw materials, where currently available raw materials are not up to standard, reported the Wall Street Journal.

The giant pharmaceutical company hopes to deliver only 50 million doses this year and removes hopes of a fast economic recovery in the aftermath of the corona virus, which is certainly needed to turn the economy back on.

RESEARCH TEAM CNBC INDONESIA

[Gambas:Video CNBC]

(which / which)


– .

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.